A setback for embryonic stem cell researchMICHAEL COOK
A milestone case in the European Court of Justice may signal a new direction in campaigns against human embryo research.
Specialists in human embryonic stem cell research were furious. "This is a devastating decision which will stop stem cell therapies use in medicine. The potential to treat disabling and life threatening diseases… using stem cells will not be realised in Europe," said Professor Pete Coffey, of University College London.
The decision does not prevent scientists from experimenting on human embryos, but they will not be able to patent their work in the European Union, making it difficult to commercialise their work. "This unfortunate decision by the Court leaves scientists in a ridiculous position," fumed Professor Austin Smith, of Cambridge University. "We are funded to do research for the public good, yet prevented from taking our discoveries to the market place where they could be developed into new medicines. One consequence is that the benefits of our research will be reaped in America and Asia."
The directive did not mention human embryonic stem cells, as the technology had not been developed at that stage. But in 2005, a resolution of the European Parliament declared that "the creation of human embryonic stem cells implies the destruction of human embryos and... therefore the patenting of procedures involving human embryonic stem cells or cells that are grown from human embryonic stem cells is a violation".
Oliver Brüstle, a leading German stem cell scientist who holds a patent on neural cells produced from human embryonic stem cells, was on the losing side of the lawsuit. His view was that the directive had not defined what an embryo is. He believed that an "embryo" comes into being 14 days after fertilisation. Since his embryonic stem cells were taken from five or six day old embryos, they could not be banned by the directive.
But this line of reasoning seems to have made no impression. The court supported a common sense understanding of an embryo and declared that "any human ovum must, as soon as fertilised, be regarded as a 'human embryo' if that fertilisation is such as to commence the process of development of a human being".
Furthermore, according to the directive, human biological material deserves to be treated with dignity. The court quoted the directive:
The European ruling sharply contrasts with a similar case brought by US researchers James Sherley and Theresa Deisher which challenged Federal funding for hESC research because it involved the destruction of embryos. After an epic legal battle over the meaning of words in the relevant legislation, a court found in July that the destruction of embryos could not be funded but that the use of embryonic stem cells could. The different result underscores significant cultural differences between the US and Continental Europe over the significance of "human dignity".
Instead, two different currents were at work in sweeping aside Brüstle's arguments: the fear of reducing human life to an industrial product and the suspicion that scientists want to evade oversight and control by democratic institutions.
Brüstle's foe was Greenpeace International. Its campaigns include protests against whaling, deforestation, pollution, nuclear power – and "radical demands" leading to the commercialisation of human life. It expressed fears that a "widespread embryo industry" might develop as a result of his research. This is consistent with its opposition to other forms of genetic manipulation, like genetically engineered foods.
Furthermore, ever since the atrocities of the Nazi era, Europeans, and Germans in particular, have been much more reluctant to trust scientists to do their research in pursuit of a higher social good without a clear and rigorous ethical analysis.
As a result, the German establishment welcomed the decision. The president of the German Medical Association, Frank Ulrich Montgomery, said that the ruling protected life from commercial interests and in any case, scientists can work with ethically uncontroversial adult stem cells. The German Research Minister, Annette Schavan, said that it was clear that "that scientific interests do not come before human life."
In the US and the UK, scientists adopt a more pragmatic, trust-me-I'm-a-scientist approach. As Robin Lovell-Badge, of the UK National Institute for Medical Research, commented, "the moral imperative" is not respecting embryos, but the utilitarian goal of "maximising the likelihood of benefits to patients". It's not language which would impress Greenpeace.
Or even the Financial Times Deutschland, which editorialised that:
Perhaps the most significant feature of the court's ruling is that it flags a convergence of interests between Greens who want to restrict scientists from meddling with the environment and pro-lifers, who wants to stop them from medding with unborn human life. This has been a consistent theme from the Vatican in recent years. As Benedict XVI said in 2009:
By and large the Greens support abortion, on which the Catholic Church is unlikely to compromise, so at best the two sides will be reluctant allies. But in the long-term, the case of Greenpeace v. Oliver Brüstle foreshadows a joint campaign to resist scientific encroachment upon the "human ecology".
Michael Cook. "A setback for embryonic stem cell research." Mercatornet (October 21, 2010).
MercatorNet is an innovative internet magazine analysing current affairs and key international news and trends which touch its readers' daily lives. If you enjoyed this article, visit MercatorNet.com for more.
For regular updates on sperm donation, surrogacy, IVF, euthanasia and other controversial bioethical issues, consider subscribing to BioEdge, a news magazine edited by Michael Cook.
Michael Cook is the editor of MercatorNet. He also edits a newsletter on developments in bioethics, BioEdge, and writes on bioethical issues for Australian and American newspapers and magazines. He lives in Melbourne.
Copyright © 2011 Mercatornet
Not all articles published on CERC are the objects of official Church teaching, but these are supplied to provide supplementary information.